Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_799b6c8cb40ea97102dceda7bfe7b5c7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39 |
filingDate |
2013-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41a72578e879e38527084fd1bd045233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4845be9b27b3d3ec6ad4a98bc36fbd0 |
publicationDate |
2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20150055666-A |
titleOfInvention |
Composition comprising hydrolysate of whey protein using alcalase for preventing or treating atopic dermatitis or allergic diseases |
abstract |
The present invention relates to a composition for preventing or treating atopic dermatitis or an allergic disease, which comprises a hydrolyzate of a whey protein using an alkaline protease, wherein a hydrolyzate obtained by selectively extracting a whey protein having a molecular weight of 3 kDa or less, -6, TNF-a and IL-13, and thus can be effectively used as a composition for the treatment of atopic dermatitis or allergic diseases. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020127409-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113226465-A |
priorityDate |
2013-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |